Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid route comparison in total knee arthroplasty
IRCT20160809029286N6Phase 3Completed
- Sponsor
- Joint Reconstruction Research Center
- Start
- Jul 1917
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid in knee osteoarthritis (OA) (3 arms), sponsored by Joint Reconstruction Research Center. Primary endpoints: Total perioperative blood loss, Pre-operative hemoglobin and 1 more. Started Jul 1917; status: completed.
02
Drugs
tranexamic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20160809029286N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160809029286N6.